載入...
A randomized controlled trial of daclizumab versus anti-thymocyte globulin induction for heart transplantation
BACKGROUND: The purpose of this study was to test the efficacy and safety of daclizumab (DZM) versus anti-thymocyte globulin (ATG) as a component of induction therapy in heart transplant recipients. METHODS: Thirty heart transplant patients were randomized to receive either ATG or DZM during inducti...
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2014
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4120716/ https://ncbi.nlm.nih.gov/pubmed/25093077 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2047-1440-3-14 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|